STEPHANIE EWALT: Open Payments
NPI 1215455753 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,090 in 57 payments from 10 companies in 2025. Trend: 2023 $186 · 2024 $761 · 2025 $1,090
Food & beverage: $991Education: $99
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 16 | $378 |
| Galderma Laboratories, L.P. | 9 | $213 |
| Janssen Biotech, Inc. | 7 | $164 |
| ABBVIE INC. | 15 | $135 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
| Incyte Corporation | 2 | $45 |
| Amgen Inc. | 2 | $42 |
| Arcutis Biotherapeutics, Inc. | 2 | $30 |
| LNHC, Inc | 1 | $18 |
| LEO Pharma Inc. | 1 | $16 |
Products named: Bimzelx, TREMFYA, SKYRIZI, NEMLUVIO, COSENTYX, OPZELURA, OTEZLA, Zoryve.
Industry payments across AZ — which companies pay providers there.
